Skip to content
Disclosery

Paradigm Biocapital Advisors LP: NUVL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on NUVL, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 5,924,433 NUVL shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 5,924,433 shares
    Change vs previous 13F +600,000 shares

    13.7% of the 13F portfolio, value $731,667,476.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 5,324,433 shares
    Change vs previous 13F +55,000 shares

    11.15% of the 13F portfolio, value $545,488,161.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 5,269,433 shares
    Change vs previous 13F 0 shares

    14.19% of the 13F portfolio, value $530,052,265.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 5,269,433 shares
    Change vs previous 13F 0 shares

    13.48% of the 13F portfolio, value $455,700,566.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 5,269,433 shares
    Change vs previous 13F 0 shares

    17.17% of the 13F portfolio, value $402,057,738.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 5,269,433 shares
    Change vs previous 13F -93,946 shares

    17.2% of the 13F portfolio, value $373,708,188.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 5,363,379 shares
    Change vs previous 13F +363,379 shares

    14.61% of the 13F portfolio, value $419,845,308.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 5,000,000 shares
    Change vs previous 13F not available

    17.9% of the 13F portfolio, value $511,500,000.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).